IIS: HL7 Standard Code Set
Mapping product names to CVX and MVX

CDC Product Names reflect manufacturer trade names, but may not be identical to those registered trade names. The reason that these names vary from the manufacturers trade name is that they must reflect a unique product. Several vaccines have the same trade name for both the pediatric and the adult formulations of a vaccine.

CVX codes are codes that indicate the product used in a vaccination. MVX codes are codes that indicate the manufacturer of a vaccine. These codes are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.

The goal of the table is to support mapping of product names to CVX and MVX codes.

Questions regarding this table should be directed to the IIS Technical Assistance Team(or use mailing address).

Available Printable versions: Excel     Pdf     Flat File    XML format

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

CDC Product Name	Short Description	CVX Code	Manufacturer	MVX Code	MVX status	Product name status	Last Updated Date
ABRYSVO	RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF	305	Pfizer, Inc	PFR	Active	Active	7/12/2023
ACAM2000	Vaccinia (smallpox, monkeypox), live	75	Emergent BioSolutions	MIP	Active	Active	6/10/2022
ACAM2000	Vaccinia (smallpox, monkeypox), live	75	Acambis, Inc	ACA	Inactive	Inactive	5/28/2010
ACEL-IMUNE	DTaP	20			Inactive	Inactive	9/1/2010
ACTHIB	Hib (PRP-T)	48	Sanofi Pasteur	PMC	Active	Active	5/28/2010
ADACEL	Tdap	115	Sanofi Pasteur	PMC	Active	Active	5/28/2010
Adenovirus types 4 and 7	Adenovirus types 4 and 7	143	Barr Laboratories	BRR	Inactive	Inactive	7/30/2019
Adenovirus types 4 and 7	Adenovirus types 4 and 7	143	TEVA Pharmaceuticals USA	TVA	Active	Active	7/23/2019
AFLURIA	Influenza, split virus, trivalent, preservative	141	bioCSL	CSL	Inactive	Inactive	9/26/2016
Afluria	Influenza, split virus, trivalent, preservative	141	Seqirus	SEQ	Active	Inactive	4/25/2024
Afluria quadrivalent, preservative free	Influenza, split virus, quadrivalent, PF	150	Seqirus	SEQ	Active	Active	5/14/2024
Afluria quadrivalent, preservative free, pediatric	Influenza, injectable,quadrivalent, preservative free, pediatric	161	Seqirus	SEQ	Active	Active	5/14/2024
Afluria quadrivalent, with preservative	Influenza, split virus, quadrivalent, preservative	158	Seqirus	SEQ	Active	Active	5/14/2024
Afluria trivalent, preservative free	Influenza, split virus, trivalent, PF	140	Seqirus	SEQ	Active	Active	5/14/2024
Afluria trivalent, with preservative	Influenza, split virus, trivalent, preservative	141	Seqirus	SEQ	Active	Active	5/14/2024
Afluria, preservative free	Influenza, split virus, trivalent, PF	140	bioCSL	CSL	Inactive	Inactive	12/15/2022
Afluria, preservative free	Influenza, split virus, trivalent, PF	140	Seqirus	SEQ	Active	Inactive	12/15/2022
AGRIFLU	Influenza, split virus, trivalent, PF	140	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	11/15/2017
Arexvy	RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF	303	GlaxoSmithKline	SKB	Active	Active	7/12/2023
AS03 adjuvant	AS03 Adjuvant	801	GlaxoSmithKline	SKB	Active	Inactive	9/11/2015
AstraZeneca COVID-19 Vaccine (Non-US tradenames include VAXZEVRIA, COVISHIELD)	COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL	210	AstraZeneca	ASZ	Active	Inactive	9/9/2025
ATTENUVAX	measles	05	Merck and Co., Inc.	MSD	Active	Inactive	4/28/2015
Bexsero	meningococcal B, OMV	163	GlaxoSmithKline	SKB	Active	Active	3/22/2016
Bexsero	meningococcal B, OMV	163	Novartis Pharmaceutical Corporation	NOV	Inactive	Active	2/2/2015
BEYFORTUS	RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months	306	Sanofi Pasteur	PMC	Active	Active	7/21/2023
BEYFORTUS	RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months	307	Sanofi Pasteur	PMC	Active	Active	7/21/2023
BIAVAX II	rubella/mumps	38			Inactive	Inactive	9/1/2010
BIOTHRAX	Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis	24	Emergent BioSolutions	MIP	Active	Active	8/9/2013
BOOSTRIX	Tdap	115	GlaxoSmithKline	SKB	Active	Active	5/28/2010
CAPVAXIVE	Pneumococcal conjugate PCV21, polysaccharide CRM197 conjugate, PF	327	Merck and Co., Inc.	MSD	Active	Active	7/11/2024
CERTIVA	DTaP	20			Inactive	Inactive	9/1/2010
CERVARIX	HPV, bivalent	118	GlaxoSmithKline	SKB	Active	Inactive	11/22/2016
COMIRNATY	COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose	208	Pfizer, Inc	PFR	Active	Active	9/6/2023
COMIRNATY	COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL	310	Pfizer, Inc	PFR	Active	Active	9/6/2023
COMIRNATY	COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose	217	Pfizer, Inc	PFR	Active	Active	9/6/2023
COMIRNATY	COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL	309	Pfizer, Inc	PFR	Active	Active	9/6/2023
COMVAX	Hib-Hep B	51	Merck and Co., Inc.	MSD	Active	Inactive	3/11/2016
CONVIDECIA (CanSino Biologics) COVID-19 Vaccine	COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology	506	CanSino Biologics, Inc	CAN	Active	Active	11/1/2022
Coronavac (Sinovac) COVID-19 Vaccine	COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)	511	Sinovac	SNV	Active	Active	7/13/2021
COVAXIN (Bharat) COVID-19 Vaccine	COVID-19 IV Non-US Vaccine (COVAXIN)	502	Bharat Biotech International Limited	BBI	Active	Active	11/1/2022
Covifenz	SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)	512	Medicago, Inc	MDO	Active	Active	4/11/2022
CYFENDUS	Anthrax, post-exposure prophylaxis	318	Emergent BioSolutions	MIP	Active	Active	11/2/2023
DAPTACEL	DTaP, 5 pertussis antigens	106	Sanofi Pasteur	PMC	Active	Active	5/28/2010
DECAVAC	Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed	113	Sanofi Pasteur	PMC	Active	Inactive	10/27/2017
DENGVAXIA	dengue fever tetravalent	56	Sanofi Pasteur	PMC	Active	Active	9/4/2019
DRYVAX	Vaccinia (smallpox, monkeypox), live	75			Inactive	Inactive	9/1/2010
DT(GENERIC)	DT (pediatric)	28	Sanofi Pasteur	PMC	Active	Inactive	12/6/2024
ENFLONSIA	RSV, mAb, clesrovimab-cfor, 0.7 mL, neonate and infant, PF	332	Merck and Co., Inc.	MSD	Active	Active	7/2/2025
ENGERIX B-PEDS	Hep B, adolescent or pediatric	08	GlaxoSmithKline	SKB	Active	Active	8/9/2013
ENGERIX-B-ADULT	Hep B, high-dosage, dialysis or IC	44	GlaxoSmithKline	SKB	Active	Active	5/28/2010
ENGERIX-B-ADULT	Hep B, adult	43	GlaxoSmithKline	SKB	Active	Active	5/28/2010
ERVEBO (Ebola Zaire Vaccine, Live)	Ebola Zaire vaccine, live, recombinant, 1mL dose	204	Merck and Co., Inc.	MSD	Active	Active	1/12/2023
Fluad	Influenza, adjuvanted, trivalent, PF	168	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	5/2/2024
Fluad	Influenza, adjuvanted, trivalent, PF	168	Seqirus	SEQ	Active	Inactive	5/2/2024
FLUAD Quadrivalent	Influenza, adjuvanted, quadrivalent, PF	205	Seqirus	SEQ	Active	Active	7/20/2020
Fluad trivalent, preservative free	Influenza, adjuvanted, trivalent, PF	168	Seqirus	SEQ	Active	Active	5/14/2024
FLUARIX	Influenza, split virus, trivalent, PF	140	GlaxoSmithKline	SKB	Active	Inactive	5/13/2024
Fluarix quadrivalent, preservative free	Influenza, split virus, quadrivalent, PF	150	GlaxoSmithKline	SKB	Active	Active	5/14/2024
Fluarix trivalent, preservative free	Influenza, split virus, trivalent, PF	140	GlaxoSmithKline	SKB	Active	Active	5/14/2024
Flublok	Influenza, recombinant, trivalent, PF	155	Protein Sciences	PSC	Active	Inactive	5/1/2024
Flublok quadrivalent	Influenza, recombinant, quadrivalent, PF	185	Protein Sciences	PSC	Active	Inactive	5/2/2019
Flublok quadrivalent, preservative free	Influenza, recombinant, quadrivalent, PF	185	Sanofi Pasteur	PMC	Active	Active	5/14/2024
Flublok trivalent, preservative free	Influenza, recombinant, trivalent, PF	155	Sanofi Pasteur	PMC	Active	Active	5/14/2024
Flucelvax	Influenza, MDCK, trivalent, PF	153	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	5/1/2024
Flucelvax quadrivalent, preservative free	Influenza, MDCK, quadrivalent, PF	171	Seqirus	SEQ	Active	Active	5/14/2024
Flucelvax quadrivalent, with preservative	Influenza, MDCK, quadrivalent, preservative	186	Seqirus	SEQ	Active	Active	5/14/2024
Flucelvax trivalent, preservative free	Influenza, MDCK, trivalent, PF	153	Seqirus	SEQ	Active	Active	5/14/2024
Flucelvax trivalent, with preservative	Influenza, MDCK, trivalent, preservative	320	Seqirus	SEQ	Active	Active	5/14/2024
FLULAVAL	Influenza, split virus, trivalent, preservative	141	ID Biomedical	IDB	Active	Inactive	4/25/2024
Flulaval quadrivalent	Influenza, split virus, quadrivalent, preservative	158	ID Biomedical	IDB	Active	Inactive	7/1/2025
Flulaval quadrivalent, preservative free	Influenza, split virus, quadrivalent, PF	150	ID Biomedical	IDB	Active	Active	5/14/2024
Flulaval trivalent, preservative free	Influenza, split virus, trivalent, PF	140	ID Biomedical	IDB	Active	Active	5/14/2024
Flulaval, preservative free	Influenza, split virus, trivalent, PF	140	ID Biomedical	IDB	Active	Inactive	12/15/2022
FLUMIST	Influenza, live, trivalent, intranasal, PF	111	MedImmune, Inc. (AstraZeneca)	MED	Active	Inactive	10/23/2015
Flumist quadrivalent	Influenza, live, quadrivalent, intranasal	149	MedImmune, Inc. (AstraZeneca)	MED	Active	Active	8/7/2012
FluMist trivalent	Influenza, live, trivalent, intranasal, PF	111	MedImmune, Inc. (AstraZeneca)	MED	Active	Active	5/14/2024
FluMist trivalent (self/caregiver administered)	Influenza, live, trivalent, intranasal, self/caregiver admin, PF	333	MedImmune, Inc. (AstraZeneca)	MED	Active	Active	7/21/2025
FLUVIRIN	Influenza, split virus, trivalent, preservative	141	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	4/25/2024
Fluvirin	Influenza, split virus, trivalent, preservative	141	Seqirus	SEQ	Active	Inactive	4/25/2024
Fluvirin preservative free	Influenza, split virus, trivalent, PF	140	Seqirus	SEQ	Active	Inactive	12/15/2022
FLUVIRIN-PRESERVATIVE FREE	Influenza, split virus, trivalent, PF	140	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	12/15/2022
FLUZONE	Influenza, split virus, trivalent, preservative	141	Sanofi Pasteur	PMC	Active	Inactive	4/25/2024
FLUZONE High-Dose Quadrivalent Southern Hemisphere	influenza, Southern Hemisphere, high-dose, quadrivalent	231	Sanofi Pasteur	PMC	Active	Active	3/14/2023
Fluzone High-Dose quadrivalent, preservative free	Influenza, high-dose, quadrivalent, PF	197	Sanofi Pasteur	PMC	Active	Active	5/14/2024
FLUZONE High-Dose Trivalent Southern Hemisphere	Influenza, Southern Hemisphere, high-dose, trivalent, PF	337	Sanofi Pasteur	PMC	Active	Active	4/9/2026
Fluzone High-Dose trivalent, preservative free	Influenza, high-dose, trivalent, PF	135	Sanofi Pasteur	PMC	Active	Active	5/14/2024
Fluzone Quad Intradermal	influenza, intradermal, quadrivalent, preservative free	166	Sanofi Pasteur	PMC	Active	Inactive	12/15/2022
FLUZONE Quadrivalent Southern Hemisphere	influenza, Southern Hemisphere, quadrivalent, with preservative	202	Sanofi Pasteur	PMC	Active	Active	3/12/2020
FLUZONE Quadrivalent Southern Hemisphere	Influenza, Southern Hemisphere, quadrivalent, PF	201	Sanofi Pasteur	PMC	Active	Active	3/12/2020
FLUZONE Quadrivalent Southern Hemisphere, Pediatric	influenza, Southern Hemisphere, pediatric, preservative free	200	Sanofi Pasteur	PMC	Active	Active	4/21/2020
Fluzone Quadrivalent, pediatric	Influenza, injectable,quadrivalent, preservative free, pediatric	161	Sanofi Pasteur	PMC	Active	Active	7/23/2014
FLUZONE Trivalent Southern Hemisphere	Influenza, Southern Hemisphere, trivalent, PF	331	Sanofi Pasteur	PMC	Active	Active	4/22/2025
Fluzone trivalent, preservative free	Influenza, split virus, trivalent, PF	140	Sanofi Pasteur	PMC	Active	Active	5/17/2024
Fluzone trivalent, with preservative	Influenza, split virus, trivalent, preservative	141	Sanofi Pasteur	PMC	Active	Active	5/14/2024
Fluzone, intradermal	influenza, seasonal, intradermal, preservative free	144	Sanofi Pasteur	PMC	Active	Inactive	12/15/2022
Fluzone, Quadrivalent	Influenza, split virus, quadrivalent, preservative	158	Sanofi Pasteur	PMC	Active	Active	8/8/2013
Fluzone, quadrivalent, preservative free	Influenza, split virus, quadrivalent, PF	150	Sanofi Pasteur	PMC	Active	Active	10/21/2014
FLUZONE-HIGH DOSE	Influenza, high-dose, trivalent, PF	135	Sanofi Pasteur	PMC	Active	Inactive	5/1/2024
FLUZONE-PRESERVATIVE FREE	Influenza, split virus, trivalent, PF	140	Sanofi Pasteur	PMC	Active	Inactive	12/15/2022
GARDASIL	HPV, quadrivalent	62	Merck and Co., Inc.	MSD	Active	Inactive	5/28/2010
Gardasil 9	HPV9	165	Merck and Co., Inc.	MSD	Active	Active	12/11/2014
HAVRIX-ADULT	Hep A, adult	52	GlaxoSmithKline	SKB	Active	Active	5/28/2010
HAVRIX-PEDS	Hep A, ped/adol, 2 dose	83	GlaxoSmithKline	SKB	Active	Active	8/9/2013
HEPLISAV-B	HepB-CpG	189	Dynavax, Inc.	DVX	Active	Active	10/27/2017
HIBERIX	Hib (PRP-T)	48	GlaxoSmithKline	SKB	Active	Active	5/28/2010
HIBTITER	Hib (HbOC)	47			Inactive	Inactive	8/18/2010
Imovax	rabies, intramuscular injection	18	Sanofi Pasteur	PMC	Active	Inactive	12/12/2016
IMOVAX	Rabies - IM Diploid cell culture	175	Sanofi Pasteur	PMC	Active	Active	10/19/2016
IMOVAX ID	rabies, intradermal injection	40	Sanofi Pasteur	PMC	Active	Inactive	11/22/2016
INFANRIX	DTaP	20	GlaxoSmithKline	SKB	Active	Active	5/28/2010
Influenza A (H5N1) -2013	Influenza A monovalent (H5N1), ADJUVANTED-2013	160	ID Biomedical	IDB	Active	Active	1/16/2014
Influenza A monovalent (H5N1), ADJUVANTED-2013	Influenza A monovalent (H5N1), ADJUVANTED-2013	160	GlaxoSmithKline	SKB	Active	Inactive	8/27/2015
IPOL	IPV	10	Sanofi Pasteur	PMC	Active	Active	5/28/2010
IXCHIQ	Chikungunya live attenuated vaccine, 0.5 mL, PF	317	Valneva	VAL	Active	Active	12/14/2023
Ixiaro	Japanese Encephalitis IM	134	Valneva	VAL	Active	Active	7/19/2016
IXIARO	Japanese Encephalitis IM	134	Intercell Biomedical	INT	Inactive	Inactive	7/19/2016
IXIARO	Japanese Encephalitis IM	134	Vetter Pharma Fertigung GmbH & Co. KG	VET	Inactive	Active	12/4/2017
Janssen (J&J) COVID-19 Vaccine	COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL	212	Janssen	JSN	Active	Inactive	9/9/2025
JE-VAX	Japanese encephalitis SC	39	The Research Foundation for Microbial Diseases of Osaka University (BIKEN)	JPN	Inactive	Inactive	4/29/2015
JYNNEOS	Vaccinia, smallpox monkeypox vaccine live, PF, SQ or ID injection	206	Bavarian Nordic A/S	BN	Active	Active	5/20/2022
KINRIX	DTaP-IPV	130	GlaxoSmithKline	SKB	Active	Active	5/28/2010
MENACTRA	meningococcal MCV4P	114	Sanofi Pasteur	PMC	Active	Inactive	6/5/2024
MENHIBRIX	Meningococcal C/Y-HIB PRP	148	GlaxoSmithKline	SKB	Active	Inactive	11/15/2017
MENOMUNE	meningococcal MPSV4	32	Sanofi Pasteur	PMC	Active	Inactive	10/27/2017
MenQuadfi	meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)	203	Sanofi Pasteur	PMC	Active	Active	5/27/2020
Menveo	Meningococcal MCV4O	136	GlaxoSmithKline	SKB	Active	Active	3/22/2016
MENVEO	Meningococcal MCV4O	136	Novartis Pharmaceutical Corporation	NOV	Inactive	Active	3/22/2016
MERUVAX II	rubella	06	Merck and Co., Inc.	MSD	Active	Inactive	4/28/2015
M-M-R II	MMR	03	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
mNEXSPIKE	COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL	334	Moderna US, Inc.	MOD	Active	Active	8/28/2025
Moderna COVID-19 Bivalent, Original + BA.1 (Non-US Tradename Spikevax Bivalent)	COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna	519	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent)	COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose	229	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename Spikevax Bivalent)	COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL	230	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Vaccine (non-US Spikevax)	COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose	221	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Vaccine (non-US Spikevax)	COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose	227	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Vaccine (non-US Spikevax)	COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose	207	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Vaccine (non-US Spikevax)	COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose	228	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
Moderna COVID-19 Vaccine (US only)	COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL	311	Moderna US, Inc.	MOD	Active	Inactive	9/9/2025
mRESVIA	RSV, mRNA, injectable, PF	326	Moderna US, Inc.	MOD	Active	Active	6/6/2024
MUMPSVAX	mumps	07			Inactive	Inactive	9/1/2010
MYCOBAX	BCG	19			Inactive	Inactive	12/11/2015
Novavax COVID-19 Vaccine (Non-US Tradenames NUVAXOVID, COVOVAX)	COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL	211	Novavax, Inc.	NVX	Active	Inactive	9/9/2025
Novavax COVID-19 Vaccine, Adjuvanted (US Only)	COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL	313	Novavax, Inc.	NVX	Active	Inactive	9/9/2025
Novel influenza-H1N1-09	Novel influenza-H1N1-09	127	bioCSL	CSL	Inactive	Inactive	8/27/2015
Novel influenza-H1N1-09	Novel influenza-H1N1-09	127	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	8/27/2015
Novel influenza-H1N1-09	Novel influenza-H1N1-09	127	Sanofi Pasteur	PMC	Active	Inactive	8/27/2015
Novel Influenza-H1N1-09, nasal	Novel Influenza-H1N1-09, nasal	125	MedImmune, Inc. (AstraZeneca)	MED	Active	Inactive	8/27/2015
Novel influenza-H1N1-09, preservative-free	Novel influenza-H1N1-09, preservative-free	126	bioCSL	CSL	Inactive	Inactive	8/27/2015
Novel influenza-H1N1-09, preservative-free	Novel influenza-H1N1-09, preservative-free	126	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	8/27/2015
Novel influenza-H1N1-09, preservative-free	Novel influenza-H1N1-09, preservative-free	126	Sanofi Pasteur	PMC	Active	Inactive	8/27/2015
NUVAXOVID	COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL	313	Novavax, Inc.	NVX	Active	Active	8/28/2025
OMNIHIB	Hib (PRP-T)	48			Inactive	Inactive	9/1/2010
ORIMUNE	OPV, trivalent	02			Inactive	Inactive	9/1/2010
PEDIARIX	DTaP-Hep B-IPV	110	GlaxoSmithKline	SKB	Active	Active	5/28/2010
PEDVAXHIB	Hib (PRP-OMP)	49	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
PENBRAYA	Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF	316	Pfizer, Inc	PFR	Active	Active	11/2/2023
PENMENVY	Meningococcal oligosaccharide (MenACWY), (MenB), PF	328	GlaxoSmithKline	SKB	Active	Active	3/18/2025
PENTACEL	DTaP-Hib-IPV	120	Sanofi Pasteur	PMC	Active	Active	5/28/2010
Pfizer COVID-19 Bivalent, Original + BA.1 (Non-US Tradename COMIRNATY Bivalent)	COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech	520	Pfizer, Inc	PFR	Active	Active	11/17/2022
Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)	COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose	302	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)	COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose	300	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Bivalent, Original + BA.4/BA.5 (Non-US Tradename COMIRNATY Bivalent)	COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose	301	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)	COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose	217	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)	COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose	218	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)	COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose	208	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (EUA labeled) COMIRNATY (BLA labeled)	COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose	219	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (US Only)	COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL	310	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
Pfizer-BioNTech COVID-19 Vaccine (US Only)	COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL	308	Pfizer, Inc	PFR	Active	Inactive	9/9/2025
PNEUMOVAX 23	pneumococcal polysaccharide PPV23	33	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
PREHEVBRIO Hepatitis B Vaccine (Recombinant)	HepB recombinant, 3-antigen, Al(OH)3	220	VBI Vaccines, Inc	VBI	Inactive	Inactive	12/10/2024
PREVNAR 13	Pneumococcal conjugate PCV 13	133	Pfizer, Inc	PFR	Active	Active	5/28/2010
PREVNAR 13	Pneumococcal conjugate PCV 13	133	Wyeth	WAL	Active	Inactive	5/28/2010
PREVNAR 20	Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF	216	Pfizer, Inc	PFR	Active	Active	8/18/2021
PREVNAR 7	pneumococcal conjugate PCV 7	100	Wyeth	WAL	Active	Inactive	9/24/2015
PREVNAR 7	pneumococcal conjugate PCV 7	100	Wyeth	WAL	Active	Inactive	9/24/2015
Priorix	MMR	03	GlaxoSmithKline	SKB	Active	Active	6/15/2022
PROHIBIT	Hib (PRP-D)	46			Inactive	Inactive	9/1/2010
PROQUAD	MMRV	94	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
Quadracel	DTaP-IPV	130	Sanofi Pasteur	PMC	Active	Active	3/26/2015
RabAvert	rabies, intramuscular injection	18	Chiron Corporation	CHI	Inactive	Inactive	3/22/2016
RABAVERT	Rabies - IM fibroblast culture	176	GlaxoSmithKline	SKB	Active	Inactive	7/25/2024
RABAVERT	Rabies - IM fibroblast culture	176	Novartis Pharmaceutical Corporation	NOV	Inactive	Inactive	10/19/2016
RABAVERT	Rabies - IM fibroblast culture	176	Bavarian Nordic A/S	BN	Active	Active	7/25/2024
RECOMBIVAX-ADULT	Hep B, adult	43	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
RECOMBIVAX-DIALYSIS	Hep B, high-dosage, dialysis or IC	44	Merck and Co., Inc.	MSD	Active	Active	8/9/2013
RECOMBIVAX-PEDS	Hep B, adolescent or pediatric	08	Merck and Co., Inc.	MSD	Active	Active	8/9/2013
ROTARIX	rotavirus, monovalent	119	GlaxoSmithKline	SKB	Active	Active	5/28/2010
ROTATEQ	rotavirus, pentavalent	116	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
Sanofi COVID-19	COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL	226	Sanofi Pasteur	PMC	Active	Inactive	9/9/2025
Sanofi COVID-19	COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL	225	Sanofi Pasteur	PMC	Active	Inactive	9/9/2025
SHINGRIX	zoster recombinant	187	GlaxoSmithKline	SKB	Active	Active	10/27/2017
Sinopharm (BIBP) COVID-19 Vaccine	COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)	510	Sinopharm-Biotech	SPH	Active	Active	7/13/2021
SPIKEVAX	COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL	311	Moderna US, Inc.	MOD	Active	Active	9/6/2023
SPIKEVAX	COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL	312	Moderna US, Inc.	MOD	Active	Active	9/6/2023
SPIKEVAX	COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose	207	Moderna US, Inc.	MOD	Active	Active	9/6/2023
Stamaril	Yellow fever vaccine live - alt	183	Sanofi Pasteur	PMC	Active	Active	3/2/2017
Td, adsorbed	Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed	09	Grifols	GRF	Active	Inactive	5/21/2019
Td, adsorbed	Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed	09	Massachusetts Biologic Laboratories	MBL	Active	Inactive	5/21/2019
TDVAX	Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed	09	Massachusetts Biologic Laboratories	MBL	Active	Active	5/21/2019
Tenivac	Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed	113	Sanofi Pasteur	PMC	Active	Active	8/9/2013
TETANUS TOXOID (GENERIC)	tetanus toxoid, adsorbed	35	Sanofi Pasteur	PMC	Active	Inactive	5/28/2010
TETRAMUNE	DTP-Hib	22			Inactive	Inactive	9/1/2010
TICE BCG	BCG	19	Merck and Co., Inc.	MSD	Active	Active	7/26/2021
TICOVAC	Tick-borne encephalitis, inactivated, PF, 0.5mL	224	Pfizer, Inc	PFR	Active	Active	11/4/2021
TICOVAC	Tick-borne encephalitis, inactivated, PF, 0.25mL	223	Pfizer, Inc	PFR	Active	Active	11/4/2021
TRIHIBIT	DTaP-Hib	50	Sanofi Pasteur	PMC	Active	Inactive	3/21/2017
TRIPEDIA	DTaP	20	Sanofi Pasteur	PMC	Active	Inactive	11/15/2017
Trumenba	meningococcal B, recombinant	162	Pfizer, Inc	PFR	Active	Active	11/3/2014
TWINRIX	Hep A-Hep B	104	GlaxoSmithKline	SKB	Active	Active	5/28/2010
TYPHIM VI	typhoid, ViCPs	101	Sanofi Pasteur	PMC	Active	Active	5/28/2010
TYPHOID-AKD	typhoid, parenteral, AKD (U.S. military)	53			Inactive	Inactive	8/9/2013
VAQTA-ADULT	Hep A, adult	52	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
VAQTA-PEDS	Hep A, ped/adol, 2 dose	83	Merck and Co., Inc.	MSD	Active	Active	8/9/2013
VARIVAX	varicella	21	Merck and Co., Inc.	MSD	Active	Active	5/28/2010
VAXCHORA	cholera, live attenuated	174	Emergent Travel Health, Inc (Formerly PaxVax)	PAX	Active	Inactive	6/12/2024
Vaxchora	cholera, live attenuated	174	Bavarian Nordic A/S	BN	Active	Active	6/12/2024
VAXELIS	DTaP,IPV,Hib,HepB	146	MSP Vaccine Company - (partnership Merck and Sanofi Pasteur)	MSP	Active	Active	7/21/2021
VAXNEUVANCE	Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF	215	Merck and Co., Inc.	MSD	Active	Active	8/18/2021
VIMKUNYA	Chikungunya, VLP, recombinant, 0.8 mL, PF	329	Bavarian Nordic A/S	BN	Active	Active	3/18/2025
Vivotif	typhoid, oral	25	Emergent Travel Health, Inc (Formerly PaxVax)	PAX	Active	Inactive	7/12/2024
VIVOTIF BERNA	typhoid, oral	25	Crucell	CRU	Inactive	Inactive	5/2/2016
Vivotif- BN	typhoid, oral	25	Bavarian Nordic A/S	BN	Active	Active	7/12/2024
YF-VAX	yellow fever live	37	Sanofi Pasteur	PMC	Active	Active	5/28/2010
ZOSTAVAX	zoster live	121	Merck and Co., Inc.	MSD	Active	Inactive	12/6/2024

 Top of Page

---

For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:

Address:

CDC, National Centers for Immunization and Respiratory Diseases
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333

Email:

iisinfo@cdc.gov (note change)

Related Pages

• IIS: HL7 Standard Code Set MVX - Manufacturers of Vaccines
• IIS: HL7 Standard Code Set CVX - Vaccines Administered